Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-17

Clinical Trial Update: Vonoprazan Fumarate in Combination With Amoxicillin for the First-line Eradication of Helicobacter Pylori -- a Multicenter, Randomized, Parallel Controlled Study [Phase 4]

View source ↗

Summary

A Phase 4 randomized multicenter trial evaluating vonoprazan fumarate with amoxicillin for first-line Helicobacter pylori eradication.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AMOXICILLIN (AMOXICILLIN)
  • vonoprazan fumarate (vonoprazan)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Helicobacter Pylori Eradication Rate | Phase 4 | Status: UNKNOWN